IFEC-CONICET, Depto. Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Brain Behav Immun. 2013 Nov;34:141-50. doi: 10.1016/j.bbi.2013.08.007. Epub 2013 Aug 20.
Pro-inflammatory cytokines can affect cognitive processes such as learning and memory. Particularly, interleukin-1β (IL-1β) influences the consolidation of hippocampus-dependent memories. We previously reported that administration of IL-1β in dorsal hippocampus impaired contextual fear memory consolidation. Different mechanisms have been implicated in the action of IL-1β on long-term potentiation (LTP), but the processes by which this inhibition occurs in vivo remain to be elucidated. We herein report that intrahippocampal injection of IL-1β induced a significant increase in p38 phosphorylation after contextual fear conditioning. Also, treatment with SB203580, an inhibitor of p38, reversed impairment induced by IL-1β on conditioned fear behavior, indicating that this MAPK would be involved in the effect of the cytokine. We also showed that IL-1β administration produced a decrease in glutamate release from dorsal hippocampus synaptosomes and that treatment with SB203580 partially reversed this effect. Our results indicated that IL-1β-induced impairment in memory consolidation could be mediated by a decrease in glutamate release. This hypothesis is sustained by the fact that treatment with d-cycloserine (DCS), a partial agonist of the NMDA receptor, reversed the effect of IL-1β on contextual fear memory. Furthermore, we demonstrated that IL-1β produced a temporal delay in ERK phosphorylation and that DCS administration reversed this effect. We also observed that intrahippocampal injection of IL-1β decreased BDNF expression after contextual fear conditioning. We previously demonstrated that α-MSH reversed the detrimental effect of IL-1β on memory consolidation. The present results demonstrate that α-MSH administration did not modify the decrease in glutamate release induced by IL-1β. However, intrahippocampal injection of α-MSH prevented the effect on ERK phosphorylation and BDNF expression induced by IL-1β after contextual fear conditioning. Therefore, in the present study we determine possible molecular mechanisms involved in the impairment induced by IL-1β on fear memory consolidation. We also established how this effect could be modulated by α-MSH.
促炎细胞因子可影响学习和记忆等认知过程。特别是白细胞介素-1β(IL-1β)影响海马体依赖记忆的巩固。我们之前的研究表明,向背侧海马体中注射 IL-1β会损害情景性恐惧记忆的巩固。已经提出了多种机制来解释 IL-1β对长时程增强(LTP)的作用,但这种抑制在体内发生的过程仍有待阐明。我们在此报告,在情景性恐惧条件作用后,向海马体中注射 IL-1β会导致 p38 磷酸化显著增加。另外,用 p38 抑制剂 SB203580 处理可逆转 IL-1β对条件性恐惧行为的损害,表明这种 MAPK 会参与细胞因子的作用。我们还表明,IL-1β 给药会导致背侧海马体突触小体中谷氨酸释放减少,而 SB203580 处理可部分逆转这种作用。我们的结果表明,IL-1β 诱导的记忆巩固受损可能是通过减少谷氨酸释放介导的。这种假设是由以下事实支持的:用 NMDA 受体部分激动剂 D-环丝氨酸(DCS)处理可逆转 IL-1β 对情景性恐惧记忆的作用。此外,我们证明,IL-1β 导致 ERK 磷酸化出现时间延迟,而 DCS 给药可逆转这种作用。我们还观察到,在情景性恐惧条件作用后,向海马体中注射 IL-1β会降低 BDNF 的表达。我们之前的研究表明,α-MSH 可逆转 IL-1β 对记忆巩固的不利影响。本研究结果表明,α-MSH 给药不能改变 IL-1β 诱导的谷氨酸释放减少。然而,向海马体中注射 α-MSH 可防止 IL-1β 对情景性恐惧条件作用后 ERK 磷酸化和 BDNF 表达的影响。因此,在本研究中,我们确定了 IL-1β 对恐惧记忆巩固产生损害所涉及的可能分子机制。我们还确定了 α-MSH 如何调节这种作用。